The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 20, 2016
Filed:
Aug. 17, 2012
Applicants:
Bertrand Leblond, Paris, FR;
Anne-sophie Casagrande, Draveil, FR;
Laurent Desire, Paris, FR;
Alicia Foucourt, Canteleu, FR;
Thierry Besson, Preaux, FR;
Inventors:
Bertrand Leblond, Paris, FR;
Anne-Sophie Casagrande, Draveil, FR;
Laurent Desire, Paris, FR;
Alicia Foucourt, Canteleu, FR;
Thierry Besson, Preaux, FR;
Assignee:
DIAXONHIT, Paris, FR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); C07D 513/04 (2006.01); A61K 31/519 (2006.01); C07C 271/28 (2006.01); C07D 277/68 (2006.01); C07C 219/04 (2006.01); C07D 277/64 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/5377 (2013.01); C07C 219/04 (2013.01); C07C 271/28 (2013.01); C07D 277/64 (2013.01); C07D 277/68 (2013.01); C07D 513/04 (2013.01);
Abstract
The present invention relates to novel thiazolo[5,4-f]quinazoline compounds and methods that are useful in the amelioration, treatment or control of Down's syndrome or early Alzheimer's disease or in the amelioration, treatment or control of cancers, especially solid tumors. More specifically, the invention relates to DYRK1A and/or DYRK1B inhibitors and to methods for preparing such compounds.